- Home
- NRC vs SPXX Comparison
NRC vs SPXX Comparison
Compare NRC & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- SPXX
- Stock Information
- Founded
- NRC 1981
- SPXX 2004
- Country
- NRC United States
- SPXX United States
- Employees
- NRC N/A
- SPXX N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- SPXX Trusts Except Educational Religious and Charitable
- Sector
- NRC Health Care
- SPXX Finance
- Exchange
- NRC Nasdaq
- SPXX Nasdaq
- Market Cap
- NRC 354.5M
- SPXX 322.7M
- IPO Year
- NRC N/A
- SPXX N/A
- Fundamental
- Price
- NRC $14.65
- SPXX $18.09
- Analyst Decision
- NRC
- SPXX
- Analyst Count
- NRC 0
- SPXX 0
- Target Price
- NRC N/A
- SPXX N/A
- AVG Volume (30 Days)
- NRC 101.8K
- SPXX 51.3K
- Earning Date
- NRC 10-24-2025
- SPXX 01-01-0001
- Dividend Yield
- NRC 3.27%
- SPXX 7.55%
- EPS Growth
- NRC N/A
- SPXX N/A
- EPS
- NRC 0.77
- SPXX N/A
- Revenue
- NRC $140,314,000.00
- SPXX N/A
- Revenue This Year
- NRC N/A
- SPXX N/A
- Revenue Next Year
- NRC N/A
- SPXX N/A
- P/E Ratio
- NRC $19.08
- SPXX N/A
- Revenue Growth
- NRC N/A
- SPXX N/A
- 52 Week Low
- NRC $9.76
- SPXX $13.57
- 52 Week High
- NRC $22.99
- SPXX $16.05
- Technical
- Relative Strength Index (RSI)
- NRC 47.80
- SPXX 57.76
- Support Level
- NRC $14.45
- SPXX $17.73
- Resistance Level
- NRC $15.60
- SPXX $18.20
- Average True Range (ATR)
- NRC 0.64
- SPXX 0.15
- MACD
- NRC -0.03
- SPXX -0.00
- Stochastic Oscillator
- NRC 17.05
- SPXX 76.60
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35%-75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.